-
Clinical trial will test long acting HIV injection
pharmafile
May 15, 2019
A long-acting, injectable HIV drug combo is to be tested in a clinical trial of 350 volunteers with HIV.
-
Gilead struck anti-competitive deals to retain dominance in HIV market, lawsuit says
pharmafile
May 15, 2019
Gilead Sciences struck anti-competitive deals with Janssen and Britsol-Myers Squibb in an effort to retain dominance in the market for HIV drugs, according to a lawsuit filed by AIDS activists and unions.
-
Clinical trial tests injectable vs oral HIV medications
europeanpharmaceuticalreview
May 15, 2019
A new clinical trial will determine if monthly injections of anti-viral drugs are more effective at suppressing the HIV virus than daily pills.
-
Gilead to donate 2.4M bottles of Truvada in push to limit HIV infections
fiercepharma
May 13, 2019
With HIV rates in the U.S. holding steady, health officials are looking to drugmakers for help containing its spread.
-
CDC: HIV Racial Disparity Measure Decreased From 2010 to 2016
drugs
May 10, 2019
CDC: HIV Racial Disparity Measure Decreased From 2010 to 2016.
-
Generic Version of Truvada Available in U.S. by Sept. 2020
drugs
May 10, 2019
Generic Version of Truvada Available in U.S. by Sept. 2020.
-
Study finds ART prevents HIV transmission between gay men
pharmaceutical-technology
May 05, 2019
A study published in The Lancet has found that taking antiretroviral therapy (ART) stops gay men passing human immunodeficiency virus (HIV) to their partners.
-
Robotic method isolates high-producing cell lines for HIV vaccine production
europeanpharmaceuticalreview
April 29, 2019
Technical advances in vaccine production should shorten the time to clinical trials, breaking the logjam of promising new candidate vaccines waiting to be tested…
-
Janssen's Symtuza around 90% effective in achieving undetectable HIV-1 viral loads, when used immediately following diagnosis
pharmafile
April 23, 2019
Janssen's Symtuza around 90% effective in achieving undetectable HIV-1 viral loads, when used immediately following diagnosis
-
Doctors cure 'bubble boy syndrome' using modified version of HIV
pharmafile
April 23, 2019
Doctors at St. Jude Children’s Research Hospital have been able to treat patients with X-linked severe combined immunodeficiency (SCID-X1)